Novel Maltogenic Amylase CoMA from Corallococcus sp. Strain EGB Catalyzes the Conversion of Maltooligosaccharides and Soluble Starch to Maltose

Applied and Environmental Microbiology
Jie ZhouZhongli Cui

Abstract

The gene encoding the novel amylolytic enzyme designated CoMA was cloned from Corallococcus sp. strain EGB. The deduced amino acid sequence contained a predicted lipoprotein signal peptide (residues 1 to 18) and a conserved glycoside hydrolase family 13 (GH13) module. The amino acid sequence of CoMA exhibits low sequence identity (10 to 19%) with cyclodextrin-hydrolyzing enzymes (GH13_20) and is assigned to GH13_36. The most outstanding feature of CoMA is its ability to catalyze the conversion of maltooligosaccharides (≥G3) and soluble starch to maltose as the sole hydrolysate. Moreover, it can hydrolyze γ-cyclodextrin and starch to maltose and hydrolyze pullulan exclusively to panose with relative activities of 0.2, 1, and 0.14, respectively. CoMA showed both hydrolysis and transglycosylation activities toward α-1,4-glycosidic bonds but not to α-1,6-linkages. Moreover, glucosyl transfer was postulated to be the major transglycosidation reaction for producing a high level of maltose without the attendant production of glucose. These results indicated that CoMA possesses some unusual properties that distinguish it from maltogenic amylases and typical α-amylases. Its physicochemical properties suggested that it has potential for ...Continue Reading

References

Jan 1, 1979·Annual Review of Microbiology·D KaiserM Dworkin
Apr 1, 1993·Applied Microbiology and Biotechnology·B S CollinsE M Doyle
Sep 3, 1999·The Journal of Biological Chemistry·J S KimB H Oh
Feb 24, 2001·Environmental Microbiology·H Reichenbach
Apr 18, 2001·The Journal of Biological Chemistry·L K SkovM Gajhede
Feb 9, 2002·Biotechnology and Applied Biochemistry·Kyung-A CheongJung-Wan Kim
Mar 30, 2002·The Journal of Biological Chemistry·Hee-Seob LeeKwan-Hwa Park
Jan 28, 2003·Journal of Molecular Biology·Hironori HondohYoshiki Matsuura
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Dec 3, 2004·Applied and Environmental Microbiology·Jiae YunSangyeol Ryu
Oct 8, 2008·Nucleic Acids Research·Brandi L CantarelBernard Henrissat
May 15, 2012·Journal of Bacteriology·Stuart HuntleyLotte Søgaard-Andersen
Dec 1, 2012·Nucleic Acids Research·Aron Marchler-BauerStephen H Bryant
Jul 26, 2013·Applied Microbiology and Biotechnology·Jong-Hyun JungCheon-Seok Park
Jan 13, 2015·Applied and Environmental Microbiology·Zhoukun LiZhongli Cui
Mar 24, 2016·Molecular Biology and Evolution·Sudhir KumarKoichiro Tamura

❮ Previous
Next ❯

Citations

Oct 28, 2019·Microbial Cell Factories·Laura Plaza-VinuesaRosario Muñoz
Aug 28, 2020·Frontiers in Bioengineering and Biotechnology·Ying XiaoJie Liu
Nov 15, 2021·Biotechnology and Applied Biochemistry·Guorong NiFei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.